ENDRA Life Sciences Inc.
NDRA
$4.09
-$0.0519-1.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.30% | 75.02% | -76.25% | -5.60% | 19.69% |
| Total Depreciation and Amortization | -28.07% | -1.72% | -14.07% | 7.78% | -10.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.20% | -113.70% | 171.89% | 1,701.65% | -89.66% |
| Change in Net Operating Assets | 128.57% | -89.06% | 191.42% | -589.19% | -55.76% |
| Cash from Operations | 13.87% | 14.69% | 8.54% | 20.45% | 2.84% |
| Capital Expenditure | 100.00% | -- | -- | -100.00% | 140.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -100.00% | 146.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 488.07% | -- | -- | -- | 1,375.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | 488.07% | -- | -100.00% | -99.98% | 1,465.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.99% | 23.16% | 8.44% | -131.44% | 409.91% |